UKLS Participants - Your data and how we handle it

The United Kingdom Lung Cancer Screening (UKLS) trial is a study of lung cancer screening in the UK.
Information for UKLS participants can be found here: www.ukls.org/participants-information.html

 Thank-you for being part of our clinical trial on the early detection of lung cancer utilising Low Dose CT Screening

Without the continued support of our participants, we would not be able to perform studies that aim to:
• determine factors associated with the risk of lung cancer (to help identify ways to select people for screening).
• identify better ways to detect lung cancer earlier, leading to earlier diagnosis, selecting patients for the best current and future treatments; all of which will contribute to improving patients' outcome and ultimately save lives.

For any enquiries relating to participation in UKLS
Professor John Field – J.K.Field@Liverpool.ac.uk (0151 794 9110)

It is important that as a participant you understand:
• What data we hold about you and where it comes from.
• That we store that data securely and only share it anonymously with approved researchers (none of whom would be able to identify you from the data)
• That the only data collected is that which is an important part of our research and helps us address our aims.
• That how we access data is governed by strict guidance – part of which is to make sure you are aware of your right to withdraw from the research at any time.
• That all of our research is ethically approved

As a participant you will have given us your consent before taking part in our study and providing information (e.g. completed a questionnaire) and /or samples (e.g. blood, sputum). You will have been provided with a patient information booklet specific to your consent form at the time of recruitment.
Should you at any time have any questions about the study, or wish to view any of the information or documents in relation to your own recruitment/agreement to take part, please do so either by contacting the individual listed above or in writing to the address below.

Additional information in relation to the UoL UKLS Trial and the research is available freely to individuals across various internet websites, e.g. University of Liverpool website, UKLS website, as well as via links within cancer research websites such as NIHR etc., all of which are openly accessible to the public. Some of these links are listed below:
http://www.liv.ac.uk/translational-medicine/research/lung-cancer/
http://www.ukls.org
https://www.journalslibrary.nihr.ac.uk/programmes/hta/096101/#/

This information does not include any personal details of participants, or identifiable clinical or research outcomes that can be traced to individuals, other than where individuals have volunteered to speak freely about their experience (e.g. when interviewed).

Frequently Asked Questions:

What data do you collect about me, where from and why do you need it?

Some of the data we collect is provided by you in the form of a questionnaire, including your name, address and contact details – these are important so that we can keep in contact with you and so that we can be sure data relates specifically to you.
The questionnaire also asks questions about your medical history (e.g. if you have had any lung diseases or if anyone in your family has had cancer) and environmental factors (including smoking) – these are important because they may be risk factors for lung cancer.
If you have specifically consented to us having access to your medical records, we also collect data about you that specifically relates to our research goals. This data may come from:
• Your medical notes (GP and hospital records) and tell us about the results of hospital tests, the type of lung cancer you have and any treatment you receive.
• In addition, we obtain information from NHS Digital in relation to:
o Cancer Registries, run by Public Health England, which provide us with details of any cancer you might suffer after joining our study. This is important information because it allows us to help find new ways of predicting lung cancer – using the data and samples you have provided.
o The Office for National Statistics, which provides information of dates and causes of death. This is important because we are very interested in what happens to you after you have been recruited into our study.
o Hospital Episode Statistics (HES) data which will give details of any hospital admissions you may undergo after you have joined our study, that might have an impact on our research.
It will be necessary to send participants’ NHS number, date of birth, first name, surname and postcode to NHS Digital so that records related to the above information can be retrieved and sent to the UKLS IT manager in order that the UKLS database can be updated. No identifiable participant information will be shared with researchers or third parties. Any linkage to other datasets for research purposes will be on an anonymised basis only – it will not be possible to identify individual participants.

Is my information kept securely?

Yes, the information and samples you provide are treated confidentially and stored securely by the University of Liverpool. Data is held on a secure server at the University of Liverpool, is password protected and only available to approved, trained staff who are aware of all the rules (and laws) about confidentiality and data protection. By keeping it safe in this way, we not only protect our participants, but also ensure our research is of the highest scientific and ethical standards. We have ethical approval and patient consent to retain the data for 20 years, which is important for us to understand the full impact of our study.

Do you share it with anyone?

We may share anonymised data with research collaborators, both UK and international, in order to undertake future research. Such research will have the relevant Ethics Committee Approval. Sharing results and data is an important part of scientific research, ensuring that the best minds have access to the best resources to tackle the important questions, and that our research can be judged fairly and used confidently to change the way that we prevent, detect and treat cancer. However, in sharing data we never identify individuals. All data used in research by us and our collaborators, or published in scientific journals, is anonymous. Before releasing data for sharing, we remove any information that might be used to identify our participants. We never release data to third parties who might try to contact you and those researchers to whom we do release data are required to sign a Data Sharing Agreement that ensures they abide by the same high standards. Data Sharing Agreements are reviewed and signed by authorised individuals from the University of Liverpool before being sent to any potential collaborator for review and signature. Any changes made by the collaborator to the Data Sharing would be reviewed by the University of Liverpool. A fully executed Data Sharing Agreement must be on file before any anonymised data is released by the UKLS research team.

It may be beneficial to work with a commercial company to develop new medical tests or treatments. We may therefore wish to share some of the samples or some of the information with other researchers working for such a company. If we do so the sample will be anonymous and no personal information about you will be disclosed. If, eventually, this research leads to any new treatment or medical test you will not benefit financially. If you wish, you can opt out of use of your data and samples by commercial companies.

How can I find out about the research that has been performed using my samples and data?

Because of the way we use your data anonymously and because this is purely research data, we are unable to share with you exactly what the results are relating specifically to you, or which studies your samples and data have been used in. However, you can find out about the work that the UKLS researchers carry out on the News page of this website, through local and national media and through our funding body, the National Institute for Health Research Health Technology Assessment Programme (NIHR HTA).

How do I withdraw from the study & what will happened to my samples and data?

We very much hope that you will continue to participate in our research and let us use your samples and data. However, as explained to you when you were recruited, you have the right to withdraw at any time and we will do our best to make sure that it is easy to do so.
If at any stage you feel you want to withdraw from the study, please contact us by telephone or e-mail (as above) and we will be happy to explain the simple procedure and provide a form that allows you to clearly state your wishes.

Professor John Field
Chief Investigator, UK Lung Cancer Screening Trial
University of Liverpool,
William Henry Duncan Building, 3rd floor,
6 West Derby Street,
Liverpool, L7 8TX.